{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:35:08Z","timestamp":1761885308664,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.acuroe.2020.11.012","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T09:01:30Z","timestamp":1637744490000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of onabotulinumtoxin A injection in male patients with detrusor overactivity after stress urinary incontinence surgery"],"prefix":"10.1016","volume":"46","author":[{"given":"L.","family":"Mateu-Arrom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Guti\u00e9rrez-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Sabiote Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mart\u00ednez Barea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Palou Redorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Errando-Smet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2020.11.012_bib0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/JU.0000000000000314","article-title":"Incontinence after prostate treatment: AUA\/SUFU guideline","volume":"202","author":"Sandhu","year":"2019","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.sxmr.2017.05.001","article-title":"Post-prostatectomy incontinence: how common and bothersome is it really?","volume":"5","author":"Trofimenko","year":"2017","journal-title":"Sex Med Rev."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13063-018-2501-2","article-title":"MASTER Study Group. Male synthetic sling versus artificial urinary sphincter trial for men with urodynamic stress incontinence after prostate surgery (MASTER): study protocol for a randomised controlled trial","volume":"19","author":"Constable","year":"2018","journal-title":"Trials."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0020","first-page":"9268","article-title":"The transobturator suburethral sling: a safe and effective option for all degrees of post prostatectomy urinary incontinence","volume":"25","author":"Sullivan","year":"2018","journal-title":"Can J Urol."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.acuro.2016.03.009","article-title":"Long-term follow-up for the treatment of male urinary incontinence with the Remeex system","volume":"40","author":"Naval\u00f3n-Monllor","year":"2016","journal-title":"Actas Urol Esp."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0030","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.juro.2011.02.021","article-title":"Implantation of artificial urinary sphincter in patients with post-prostatectomy incontinence, and preoperative overactive bladder and mixed symptoms","volume":"185","author":"Lai","year":"2011","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.eururo.2017.01.037","article-title":"Persistence and adherence with mirabegron versus antimuscarinic agents in patients with overactive bladder: a retrospective observational study in UK clinical practice","volume":"72","author":"Chapple","year":"2017","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/nau.22598","article-title":"The efficacy and safety of onabotulinumtoxinA in treating idiopathic OAB: a systematic review and meta-analysis","volume":"34","author":"Cui","year":"2015","journal-title":"Neurourol Urodyn."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol."},{"issue":"Suppl 3","key":"10.1016\/j.acuroe.2020.11.012_bib0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bju.13110","article-title":"Botulinum toxin (OnabotulinumtoxinA) in the male non-neurogenic overactive bladder: clinical and quality of life outcomes","volume":"116","author":"Habashy","year":"2015","journal-title":"BJU Int."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0055","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0060","unstructured":"Sociedad Andaluza de Medicina Intensiva y Unidades Coronarias. \u00cdndice de Comorbilidad de Charlson (CCI). Available from: http:\/\/www.samiuc.es\/indice-de-comorbilidad-de-charlson-cci\/ [Accessed 9 August 2019]."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nau.20798","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"29","author":"Haylen","year":"2010","journal-title":"Neurourol Urodyn."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.1999.00121.x","article-title":"Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function","volume":"84","author":"Abrams","year":"1999","journal-title":"BJU Int."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0075","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.urology.2008.05.033","article-title":"Validation of treatment benefit scale for assessing subjective outcomes in treatment of overactive bladder","volume":"72","author":"Colman","year":"2008","journal-title":"Urology."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.medcli.2011.11.013","article-title":"[Spanish cultural adaptation and psychometrical validation of the Treatment Benefit Scale (TBS) in the symptomatic treatment of overactive bladder]","volume":"140","author":"Errando-Smet","year":"2013","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0085","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg."},{"issue":"2S","key":"10.1016\/j.acuroe.2020.11.012_bib0090","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1016\/j.juro.2016.10.109","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"197","author":"Nitti","year":"2017","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0095","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/nau.23196","article-title":"Long-term compliance and results of intravesical botulinum toxin A injections in male patients","volume":"36","author":"Rahnama\u2019i","year":"2017","journal-title":"Neurourol Urodyn."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jpurol.2006.06.005","article-title":"Hazard of botulinum toxin type A injection into the detrusor in patients with an artificial urinarysphincter","volume":"2","author":"Mazzone","year":"2006","journal-title":"J Pediatr Urol."},{"key":"10.1016\/j.acuroe.2020.11.012_bib0105","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.urology.2018.09.016","article-title":"Onabotulinum toxin A injections in men with refractory idiopathic detrusor overactivity","volume":"123","author":"Faure Walker","year":"2019","journal-title":"Urology."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578621001396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578621001396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:14:41Z","timestamp":1761880481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578621001396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2173578621001396"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2020.11.012","relation":{},"ISSN":["2173-5786"],"issn-type":[{"type":"print","value":"2173-5786"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of onabotulinumtoxin A injection in male patients with detrusor overactivity after stress urinary incontinence surgery","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2020.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2020.11.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}